Gene · 667
Papers2,071
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 2,071
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Uterine Patterning, Endometrial Gland Development, and Implantation Failure in Mice Exposed Neonatally to Genistein. | Environ Health Perspect | 2020 | 32186404 | PubTator, text mining | PubMed |
| Tumor necrosis factor α in aGVHD patients contributed to the impairment of recipient bone marrow MSC stemness and deficiency of their hematopoiesis-promotion capacity. | Stem Cell Res Ther | 2020 | 32183881 | PubTator, text mining | PubMed |
| Inactivation of Transcriptional Repressor Capicua Confers Sorafenib Resistance in Human Hepatocellular Carcinoma. | Cell Mol Gastroenterol Hepatol | 2020 | 32169577 | PubTator, text mining | PubMed |
| Bisphenol A affects ovarian development in adolescent mice caused by genes expression change. | Gene | 2020 | 32156529 | PubTator, text mining | PubMed |
| Identification of key differentially expressed genes and gene mutations in breast ductal carcinoma in situ using RNA-seq analysis. | World J Surg Oncol | 2020 | 32156290 | PubTator, text mining | PubMed |
| Edgetic perturbation signatures represent known and novel cancer biomarkers. | Sci Rep | 2020 | 32152446 | PubTator, text mining | PubMed |
| Effects of prenatal bisphenol A exposure on the hepatic transcriptome and proteome in rat offspring. | Sci Total Environ | 2020 | 32145629 | PubTator, text mining | PubMed |
| Identification of rare variants in novel candidate genes in pulmonary atresia patients by next generation sequencing. | Comput Struct Biotechnol J | 2020 | 32128068 | PubTator, text mining | PubMed |
| Identification of a rare SEPT9 variant in a family with autosomal dominant Charcot-Marie-Tooth disease. | BMC Med Genet | 2020 | 32122354 | PubTator, text mining | PubMed |
| Systemic Analysis of RNA Alternative Splicing Signals Related to the Prognosis for Head and Neck Squamous Cell Carcinoma. | Front Oncol | 2020 | 32117741 | PubTator, text mining | PubMed |
| Genetic Profile and Functional Proteomics of Anal Squamous Cell Carcinoma: Proposal for a Molecular Classification. | Mol Cell Proteomics | 2020 | 32107283 | PubTator, text mining | PubMed |
| Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials. | Lancet Oncol | 2020 | 32105622 | PubTator, text mining | PubMed |
| Clinical and functional patient characteristics predict medical needs in older patients at risk of functional decline. | BMC Geriatr | 2020 | 32085737 | PubTator, text mining | PubMed |
| Binding of the periplakin linker requires vimentin acidic residues D176 and E187. | Commun Biol | 2020 | 32081916 | PubTator, text mining | PubMed |
| Comparison of C3d immunohistochemical staining to enzyme-linked immunosorbent assay and immunofluorescence for diagnosis of bullous pemphigoid. | J Am Acad Dermatol | 2020 | 32068042 | PubTator, text mining | PubMed |
| Dyshidrosiform Bullous Pemphigoid: Case Reports and Review. | Cureus | 2020 | 32064205 | PubTator, text mining | PubMed |
| Autoantibodies as diagnostic markers and potential drivers of inflammation in ulcerative colitis. | PLoS One | 2020 | 32050001 | PubTator, text mining | PubMed |
| Role of BP230 autoantibodies in bullous pemphigoid. | J Dermatol | 2020 | 32048350 | PubTator, text mining | PubMed |
| HSAN-VI: A spectrum disorder based on dystonin isoform expression. | Neurol Genet | 2020 | 32042917 | PubTator, text mining | PubMed |
| New HER2-negative breast cancer subtype responsive to anti-HER2 therapy identified. | J Cancer Res Clin Oncol | 2020 | 32036454 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/667/papers?page=37